MRI BRAIN STROKE PROTOCKOL WITH AND WITHOUT CONTRAST (DELDC) at Dr. Essa Lab

MRI BRAIN STROKE PROTOCKOL WITH AND WITHOUT CONTRAST (DELDC) at Dr. Essa Lab

The MRI BRAIN STROKE PROTOCKOL WITH AND WITHOUT CONTRAST (DELDC) at Dr. Essa Lab is a highly specialized, rapid-acquisition neuroimaging examination designed to evaluate patients presenting with acute neurological deficits. Stroke is a medical emergency where “time is brain.” Every minute of cerebral ischemia results in the loss of millions of neurons. Therefore, rapid and highly precise diagnostic imaging is paramount to differentiate between ischemic and hemorrhagic strokes, identify stroke mimics, and guide immediate clinical interventions such as intravenous thrombolysis or mechanical thrombectomy. Dr. Essa Lab, a pioneer in diagnostic excellence in Karachi, Pakistan, utilizes state-of-the-art high-field Magnetic Resonance Imaging (MRI) systems to perform this critical protocol, ensuring exceptional contrast resolution and diagnostic accuracy.

This advanced imaging protocol works by utilizing powerful magnetic fields and radiofrequency pulses to excite hydrogen protons within the brain tissue. Unlike Computed Tomography (CT), which relies on ionizing radiation, MRI offers unparalleled soft-tissue contrast, allowing for the detection of hyperacute ischemic changes within minutes of symptom onset. The protocol incorporates multiple specialized sequences, including Diffusion-Weighted Imaging (DWI), Apparent Diffusion Coefficient (ADC) mapping, Fluid-Attenuated Inversion Recovery (FLAIR), Gradient Echo (GRE) or Susceptibility-Weighted Imaging (SWI), and T1- and T2-weighted sequences. The addition of a gadolinium-based contrast agent provides critical information regarding blood-brain barrier integrity, tissue perfusion, and the presence of underlying vascular malformations, inflammatory processes, or neoplastic lesions that may mimic acute stroke symptoms.

The anatomical structures evaluated during this comprehensive examination include the cerebral cortex, subcortical white matter, deep gray matter nuclei (such as the basal ganglia and thalamus), the brainstem, the cerebellum, the ventricular system, and the intracranial vasculature. By assessing these structures, neuroradiologists can pinpoint the exact vascular territory affected, estimate the volume of the ischemic core, and identify salvageable brain tissue (the ischemic penumbra). This examination is indispensable for neurologists, neurosurgeons, and emergency medicine specialists who require definitive diagnostic clarity to formulate life-saving treatment strategies.

Clinical Procedure: What to Expect

Patient Preparation

To ensure patient safety and obtain the highest quality diagnostic images, specific preparation guidelines must be followed prior to undergoing the MRI BRAIN STROKE PROTOCKOL WITH AND WITHOUT CONTRAST (DELDC) at Dr. Essa Lab:

• Metal Screening: Patients must remove all metallic objects, including jewelry, watches, hairpins, hearing aids, and clothing with metallic zippers or buttons, as the strong magnetic field can attract these objects or cause image artifacts.
• Implants and Devices: It is mandatory to inform the MRI technologist if the patient has any internal medical devices, such as pacemakers, implantable cardioverter-defibrillators (ICDs), cochlear implants, aneurysm clips, or metallic fragments in the eyes.
• Renal Function Testing: Since this protocol involves the administration of a gadolinium-based contrast agent, patients must provide a recent Serum Creatinine and estimated Glomerular Filtration Rate (eGFR) report to ensure safe renal clearance.
• Fasting Guidelines: Patients are generally advised to fast for 4 to 6 hours prior to the scan to minimize the risk of nausea or vomiting associated with contrast administration, although emergency cases may be managed differently under medical supervision.
• Comfortable Attire: Patients should wear loose, comfortable clothing or change into a provided hospital gown before entering the MRI suite.

During the Procedure

The procedure is conducted by highly trained MRI technologists and monitored by consultant radiologists at Dr. Essa Lab. The process involves several key steps:

• Patient Positioning: The patient is placed in a supine position on the motorized MRI scanner table. A specialized head coil, which acts as an antenna to transmit and receive radiofrequency signals, is positioned over the patient’s head. Comfort pads and straps may be used to help the patient remain completely still.
• Intravenous Access: An intravenous (IV) catheter is inserted into a vein in the patient’s arm to facilitate the administration of the gadolinium-based contrast agent during the second half of the examination.
• Scanning Process: The table slowly glides into the bore of the MRI scanner. The scanner is highly automated and will run a series of rapid sequences. The patient will hear loud tapping, knocking, or buzzing sounds as the gradient coils switch on and off. Earplugs or specialized headphones are provided to reduce noise levels.
• Contrast Administration: Midway through the scan, the technologist will inject the gadolinium contrast agent through the IV line. Patients may experience a transient cold sensation in their arm or a mild metallic taste in their mouth, which is entirely normal.
• Duration and Safety: The entire protocol typically takes between 30 to 45 minutes. The technologist monitors the patient continuously through an observation window and communicates via an intercom system. A panic squeeze-ball is provided to the patient to signal the technologist immediately if they experience any discomfort or severe claustrophobia.

When is a MRI BRAIN STROKE PROTOCKOL WITH AND WITHOUT CONTRAST (DELDC) Performed?

Evaluation of Acute Ischemic Stroke

This protocol is primarily performed when a patient presents with sudden-onset neurological deficits suggestive of an acute ischemic stroke. Symptoms such as unilateral facial drooping, acute hemiparesis (weakness of the arm or leg), sudden sensory loss, acute aphasia (difficulty speaking or understanding speech), and ataxia (loss of balance) warrant immediate imaging. The Diffusion-Weighted Imaging (DWI) sequence is highly sensitive, detecting cellular swelling (cytotoxic edema) within 30 minutes of arterial occlusion, allowing clinicians to initiate thrombolytic therapy within the critical therapeutic window.

Assessment of Transient Ischemic Attack (TIA)

A Transient Ischemic Attack (TIA), often referred to as a “mini-stroke,” is a temporary episode of neurological dysfunction caused by focal brain ischemia without permanent infarction. Physicians request this protocol for TIA patients to identify any subclinical tissue injury, evaluate the intracranial vasculature for severe stenosis, and stratify the patient’s risk for a subsequent, major ischemic stroke. Identifying microvascular changes or silent infarcts helps in optimizing secondary prevention strategies, such as antiplatelet therapy and carotid artery interventions.

Detection of Intracranial Hemorrhage and Vascular Malformations

Differentiating between an ischemic stroke and an intracranial hemorrhage is critical, as the treatments are diametrically opposed. This protocol utilizes susceptibility-sensitive sequences like GRE or SWI to rapidly detect acute parenchymal, subarachnoid, or subdural hemorrhage. Furthermore, the administration of contrast medium helps in identifying underlying vascular anomalies, such as arteriovenous malformations (AVMs), dural arteriovenous fistulas, developmental venous anomalies, or cerebral aneurysms that may have ruptured or predisposed the patient to stroke.

Differentiation of Stroke Mimics

Many non-vascular neurological conditions can present with symptoms identical to an acute stroke, including primary brain tumors, metastatic disease, brain abscesses, localized encephalitis, demyelinating diseases (such as multiple sclerosis), and complicated migraines. The contrast-enhanced sequences in this protocol are invaluable for demonstrating abnormal blood-brain barrier breakdown, peripheral ring enhancement, or dural enhancement, enabling the neuroradiologist to confidently differentiate these pathological entities from an acute ischemic event.

Monitoring Post-Stroke Recovery and Complications

In patients with a known history of stroke, this protocol is performed to assess the evolution of the infarct, evaluate the development of hemorrhagic transformation (a serious complication of ischemic stroke), and monitor the efficacy of therapeutic interventions. Contrast-enhanced imaging helps assess luxury perfusion (reactive hyperemia) and the chronic remodeling of brain tissue, providing prognostic information regarding the patient’s long-term neurological recovery and potential for functional rehabilitation.

What Does a MRI BRAIN STROKE PROTOCKOL WITH AND WITHOUT CONTRAST (DELDC) Detect?

The MRI BRAIN STROKE PROTOCKOL WITH AND WITHOUT CONTRAST (DELDC) is capable of detecting a wide array of acute, subacute, and chronic neurological conditions. The primary findings include:

• Acute Ischemic Infarction: Identified by restricted diffusion on DWI with corresponding signal hypointensity on the ADC map, representing cytotoxic edema.
• Hyperacute Stroke: Ischemic changes visible within minutes of onset, before any structural abnormalities appear on conventional T2 or FLAIR sequences.
• Subacute Infarction: Characterized by vasogenic edema, showing hyperintensity on T2/FLAIR and cortical gyral enhancement on post-contrast T1-weighted images.
• Chronic Infarction: Areas of encephalomalacia and gliosis, presenting as tissue loss with CSF-like signal intensity on all sequences.
• Lacunar Infarcts: Small, deep cerebral infarcts located in the basal ganglia, internal capsule, or brainstem, resulting from occlusion of penetrating arteries.
• Hemorrhagic Transformation: Bleeding within an area of recent ischemic infarction, visible as signal loss on SWI/GRE sequences.
• Acute Intracerebral Hemorrhage: Focal blood collection within the brain parenchyma, showing characteristic signal evolution based on the age of the hematoma.
• Subarachnoid Hemorrhage: Blood within the subarachnoid spaces and sulci, best visualized on FLAIR and SWI sequences.
• Subdural and Epidural Hematomas: Extra-axial fluid collections causing mass effect and compression of the adjacent brain parenchyma.
• Cerebral Venous Sinus Thrombosis (CVST): Occlusion of the dural venous sinuses, identified by the absence of normal flow voids and abnormal contrast enhancement.
• Intracranial Arterial Stenosis: Significant narrowing of major cerebral arteries (e.g., middle cerebral artery, internal carotid artery) due to atherosclerosis.
• Arterial Occlusion: Complete blockage of an intracranial vessel, often associated with a “hyperintense vessel sign” on FLAIR.
• Cerebral Aneurysms: Focal dilations of arterial walls, posing a risk of rupture and subarachnoid hemorrhage.
• Arteriovenous Malformations (AVMs): Tangles of abnormal blood vessels (nidus) with early draining veins, demonstrating complex flow voids.
• Primary Brain Tumors: Neoplasms such as glioblastomas or astrocytomas, showing mass effect, surrounding vasogenic edema, and heterogeneous contrast enhancement.
• Metastatic Disease: Multiple well-circumscribed lesions at the gray-white matter junction, typically demonstrating intense nodular or ring enhancement.
• Brain Abscess: Focal infectious collection showing central restricted diffusion (bright on DWI) and a smooth, thin, ring-enhancing wall.
• Encephalitis: Inflammatory changes of the brain parenchyma, often involving the temporal lobes in herpes simplex encephalitis.
• Meningitis: Inflammation of the meninges, characterized by diffuse, linear leptomeningeal enhancement on post-contrast images.
• Demyelinating Plaques: Active or chronic lesions of multiple sclerosis, typically oriented perpendicular to the ventricles (Dawson’s fingers).
• Cerebral Amyloid Angiopathy: Multiple lobar microbleeds, best detected as focal “blooming” artifacts on SWI/GRE sequences.
• Hypoxic-Ischemic Encephalopathy: Diffuse, symmetric injury to the cerebral cortex and deep gray matter nuclei due to systemic hypoxia.
• Posterior Reversible Encephalopathy Syndrome (PRES): Vasogenic edema predominantly affecting the white matter of the parieto-occipital regions.
• Vascular Dementia: Widespread subcortical ischemic white matter injury (leukoaraiosis) and multiple silent lacunar infarcts.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that time is of the essence when dealing with potential stroke cases. The imaging data acquired during the MRI BRAIN STROKE PROTOCKOL WITH AND WITHOUT CONTRAST (DELDC) is immediately transferred to our advanced Picture Archiving and Communication System (PACS). Our team of highly qualified consultant neuroradiologists reviews the sequences systematically to generate a comprehensive, accurate diagnostic report. For routine or outpatient cases, reports are typically finalized and made available within 24 to 48 hours. However, in acute or emergency scenarios, preliminary findings are communicated immediately to the referring physician to facilitate prompt clinical decision-making. Patients can conveniently access and download their high-resolution diagnostic reports and digital images online through the secure Dr. Essa Lab web portal or mobile application, eliminating the need for unnecessary travel. Physical copies of reports and films can also be collected from the primary diagnostic center where the scan was performed.

MRI BRAIN STROKE PROTOCKOL WITH AND WITHOUT CONTRAST (DELDC) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Brain Parenchyma	Symmetric gray-white matter differentiation; normal signal intensity on all sequences; no restricted diffusion.	Focal restricted diffusion (DWI bright, ADC dark) indicating acute ischemia; hyperintensity on T2/FLAIR representing edema, demyelination, or tumor.
Cerebral Vasculature	Normal caliber and course of major intracranial arteries; symmetric flow voids in major vessels.	Focal stenosis, complete arterial occlusion, aneurysmal dilatation, or abnormal vascular nidus (AVM).
Ventricular System & CSF Spaces	Normal size and configuration of ventricles, sulci, and cisterns; no midline shift or mass effect.	Ventricular compression, midline shift due to mass effect, hydrocephalus, or effacement of cerebral sulci.
Meninges	No abnormal dural or leptomeningeal enhancement on post-contrast T1-weighted images.	Diffuse or focal linear leptomeningeal or pachymeningeal enhancement indicating meningitis, neurosarcoidosis, or carcinomatosis.
Brainstem & Cerebellum	Normal morphology and signal intensity; intact cranial nerve pathways; symmetric cerebellar hemispheres.	Ischemic infarction, demyelinating plaques, brainstem glioma, or cerebellar hemorrhage.
Contrast Enhancement	No abnormal parenchymal, meningeal, or vascular enhancement.	Focal nodular, ring-like, or gyral enhancement indicating blood-brain barrier disruption (subacute stroke, tumor, abscess).
Susceptibility (GRE/SWI)	No abnormal areas of signal loss or “blooming” artifacts.	Focal blooming artifacts indicating acute intraparenchymal blood, subarachnoid hemorrhage, or multiple microbleeds (amyloid angiopathy).

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for MRI BRAIN STROKE PROTOCKOL WITH AND WITHOUT CONTRAST (DELDC)?

• Experienced healthcare professionals: Our diagnostic team includes highly qualified consultant neuroradiologists and certified MRI technologists specializing in acute neuroimaging.
• Patient-focused care: We prioritize patient comfort, safety, and dignity, providing compassionate support throughout the entire imaging process.
• Quality diagnostic services: Dr. Essa Lab is committed to delivering the highest standards of diagnostic accuracy, adhering to strict international quality control protocols.
• Professional reporting: We provide detailed, structured, and clinically actionable reports to assist referring physicians in making timely treatment decisions.
• Modern diagnostic approach: Our facilities are equipped with advanced high-field MRI scanners capable of performing rapid, high-resolution stroke protocols.
• Comfortable environment: Our diagnostic centers are designed to offer a calm, clean, and reassuring atmosphere to minimize patient anxiety and claustrophobia.
• Convenient location: With an extensive network of branches across Karachi and other major cities, patients can easily access our diagnostic services.
• Commitment to accurate diagnosis: Serving the community since 1987, Dr. Essa Lab has built a legacy of trust, reliability, and excellence in healthcare diagnostics.